Physical activity and prostate tumor vessel morphology: Data from the health professionals follow-up study

Cancer Prevention Research

Volumn 8, Issue 10, 2015, Pages 962-967

  Van Blarigan, Erin L ^a,b   Gerstenberger, John P ^a   Kenfield, Stacey A ^b,c   Giovannucci, Edward L ^c,d   Stampfer, Meir J ^c,d   Jones, Lee W ^e   Clinton, Steven K ^f   Chan, June M ^a,b   Mucci, Lorelei A ^c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^f THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD VESSEL PARAMETERS; CAPILLARY DENSITY; COHORT ANALYSIS; ENDOTHELIUM CELL; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC EQUIVALENT; MICROVASCULATURE; MORPHOLOGY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE TUMOR; TUMOR VASCULARIZATION; WALKING; EXERCISE; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MOTOR ACTIVITY; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY; QUESTIONNAIRE; VASCULARIZATION;

ADULT; AGED; COHORT STUDIES; EXERCISE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOTOR ACTIVITY; NEOVASCULARIZATION, PATHOLOGIC; PROSTATIC NEOPLASMS; SURVEYS AND QUESTIONNAIRES;

EID: 84943244247     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-15-0132     Document Type: Article

References (24)

1. DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin 2014;64:252-71.
2. Richman EL, Kenfield SA, Stampfer MJ, Paciorek A, Carroll PR, Chan JM. Physical activity after diagnosis and risk of prostate cancer progression: data from the cancer of the prostate strategic urologic research endeavor. Cancer Res 2011;71:3889-95.
3. Kenfield SA, Stampfer MJ, Giovannucci E, Chan JM. Physical activity and survival after prostate cancer diagnosis in the health professionals followup study. J Clin Oncol 2011;29:726-32.
4. Betof AS, Lascola CD, Weitzel D, Landon C, Scarbrough PM, Devi GR, et al. Modulation of murine breast tumor vascularity, hypoxia and chemotherapeutic response by exercise. J Natl Cancer Inst 2015;107:pii: djv040.
5. Jones LW, Antonelli J, Masko EM, Broadwater G, Lascola CD, Fels D, et al. Exercise modulation of the host-tumor interaction in an orthotopic model of murine prostate cancer. J Appl Physiol 2012;113:263-72.
6. Zheng X, Cui XX, Huang MT, Liu Y, Wagner GC, Lin Y, et al. Inhibition of progression of androgen-dependent prostate LNCaP tumors to androgen independence in SCID mice by oral caffeine and voluntary exercise. Nutr Cancer 2012;64:1029-37.
7. Zheng X, Cui XX, Gao Z, Zhao Y, Shi Y, Huang MT, et al. Inhibitory effect of dietary atorvastatin and celecoxib together with voluntary running wheel exercise on the progression of androgen-dependent LNCaP prostate tumors to androgen independence. Exp Ther Med 2011;2:221-8.
8. Zheng X, Cui XX, Huang MT, Liu Y, Shih WJ, Lin Y, et al. Inhibitory effect of voluntary running wheel exercise on the growth of human pancreatic Panc-1 and prostate PC-3 xenograft tumors in immunodeficientmice. Oncol Rep 2008;19:1583-8.
9. Esser KA, Harpole CE, Prins GS, Diamond AM. Physical activity reduces prostate carcinogenesis in a transgenic model. Prostate 2009;69:1372-7.
10. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
11. Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: A review. Cancer Res 1989;49:6449-65.
12. Goel S, Duda DG, Xu L, Munn LL, Boucher Y, Fukumura D, et al. Normalization of the vasculature for treatment of cancer and other diseases. Physiol Rev 2011;91:1071-121.
13. Mazzone M, Dettori D, Leite de Oliveira R, Loges S, Schmidt T, Jonckx B, et al. Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell 2009;136:839-51.
14. Tretiakova M, Antic T, Binder D, Kocherginsky M, Liao C, Taxy JB, et al. Microvessel density is not increased in prostate cancer: digital imaging of routine sections and tissue microarrays. Hum Pathol 2013;44: 495-502.
15. Mucci LA, Powolny A, Giovannucci E, Liao Z, Kenfield SA, Shen R, et al. Prospective study of prostate tumor angiogenesis and cancer-specific mortality in the health professionals follow-up study. J Clin Oncol 2009;27:5627-33.
16. McCullough DJ, Nguyen LM, Siemann DW, Behnke BJ. Effects of exercise training on tumor hypoxia and vascular function in the rodent preclinical orthotopic prostate cancer model. J Appl Physiol 2013;115: 1846-54.
17. McCullough DJ, Stabley JN, SiemannDW,Behnke BJ. Modulation of blood flow, hypoxia, and vascular function in orthotopic prostate tumors during exercise. J Natl Cancer Inst 2014;106:dju036.
18. Chasan-Taber S, Rimm EB, Stampfer MJ, Spiegelman D, Colditz GA, Giovannucci E, et al. Reproducibility and validity of a self-Administered physical activity questionnaire for male health professionals. Epidemiology 1996;7:81-6.
19. Ainsworth BE, Haskell WL, Herrmann SD, Meckes N, Bassett DR Jr, Tudor-Locke C, et al. 2011 compendium of physical activities: A second update of codes and MET values. Med Sci Sports Exerc 2011;43:1575-81.
20. Bettencourt MC, Bauer JJ, Sesterhenn IA, Connelly RR, Moul JW. CD34 immunohistochemical assessment of angiogenesis as a prognostic marker for prostate cancer recurrence after radical prostatectomy. J Urol 1998;160:459-65.
21. de la Taille A, Katz AE, Bagiella E, Buttyan R, Sharir S, Olsson CA, et al. Microvessel density as a predictor of PSA recurrence after radical prostatectomy. A comparison of CD34 and CD31. Am J Clin Pathol 2000; 113:555-62.
22. Lekas A, Lazaris AC, Deliveliotis C, Chrisofos M, Zoubouli C, LapasD, et al. The expression of hypoxia-inducible factor-1alpha (HIF-1alpha) and angiogenesis markers in hyperplastic and malignant prostate tissue. Anticancer Res 2006;26:2989-93.
23. Zu K, Mucci L, Rosner BA, Clinton SK, Loda M, Stampfer MJ, et al. Dietary lycopene, angiogenesis, and prostate cancer: A prospective study in the prostate-specific antigen era. J Natl Cancer Inst 2014;106:djt430.
24. Jones LW, Viglianti BL, Tashjian JA, Kothadia SM, Keir ST, Freedland SJ, et al. Effect of aerobic exercise on tumor physiology in an animal model of human breast cancer. J Appl Physiol 2010;108:343-8.